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Abstract  
Talin is a mechanosensitive adapter protein which couples integrins to the cytoskeleton and 
regulates integrin-mediated adhesion. Talin rod domain-containing protein-1 (TLNRD1) 
shares 22% homology with the R7R8 domains of talin, and is highly conserved throughout 
vertebrate evolution, however little is known about its function. Here we show that TLNRD1 is 
an α-helical protein which shares the same atypical topology as talin R7R8, but forms a novel 
antiparallel dimer arrangement. Actin co-sedimentation assays and electron microscopy 
reveal TLNRD1 is an actin-bundling protein that forms tight actin bundles. In addition, TLNRD1 
binds to the same LD-motif containing proteins, RIAM and KANK, as talin, and thus may act 
in competition with talin. Filopodia are cell protrusions supported by tightly bundled actin 
filaments and TLNRD1 localises to filopodia tips, increases filopodia number and promotes 
cell migration in 2D. Together our results suggest that TLNRD1 has similar functionality to talin 




Talin rod domain-containing protein 1 (TLNRD1) is an evolutionarily conserved yet little 
studied protein that shares high sequence homology with the central region of the cytoskeletal 
protein talin. TLNRD1 was originally named Mesoderm Development Candidate 1 (MESDC1) 
because the gene, located on human chromosome 15, mapped to the mesd locus essential 
for mesoderm development (Holdener et al., 1994; Wines et al., 2001). This region contains 
two genes, Mesdc1 and Mesdc2, and further analysis showed that the Mesdc2 gene product, 
now renamed to MESD, was essential for mesoderm differentiation and embryonic polarity 
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(Hsieh et al., 2003; Holdener-Kenny et al., 1992). In contrast, the Mesdc1 gene was unable to 
rescue the lethal phenotype produced by deletion of the mesd gene region, suggesting the 
name was misleading. Thus, MESDC1 has been largely ignored, and it was renamed Talin 
Rod Domain-Containing Protein 1 (TLNRD1) by the HUGO Gene Nomenclature Committee 
(Yates et al., 2017) reflecting its similarity to the R7R8 region of talin. 
Talin1 and 2 are cytoplasmic adapters that provide a direct mechanosensitive link between 
the integrin family of cell adhesion molecules and the actin cytoskeleton (Calderwood et al., 
2013; Goult et al., 2018). Talins are comprised of an N-terminal atypical FERM domain (Elliott 
et al., 2010), coupled via a flexible linker to a large rod domain comprised of 63 helices 
arranged into 13 helical bundles, R1-R13 (Fig.1A) (Goult et al., 2013; Gough and Goult, 2018). 
Twelve of the rod domains are arranged linearly, end-to-end to create the large extended talin 
rod domain which unfolds and stretches in response to mechanical force (Yao et al., 2016). 
However, the central region of the talin rod, comprising domains R7R8, adopts a unique fold, 
where R8, a 4-helix bundle, is inserted into a loop between two helices of the R7 5-helix bundle 
(Gingras et al., 2010) creating a branch in the talin rod (Fig. 1A). Our initial characterisation of 
R7R8 was facilitated by its sequence homology to TLNRD1; talin residues 1359-1659 show 
22% identity to residues 44-352 of TLNRD1 (Fig. S1A) (Gingras et al., 2010), and this 
homology enabled us to pinpoint the nine helices that comprise talin R7R8, and facilitated 
resolution of the talin rod domain structure.  
Talin domains R7R8 are emerging as a major signalling hub in talin, linking diverse 
cytoskeletal elements together (Goult et al., 2018). It forms part of a major actin-binding site 
in talin (termed ABS2) that spans R4-R8 (Atherton et al., 2015; Kumar et al., 2016; Hemmings 
et al., 1996). Interestingly, the unique topology of R7R8 positions R8 outside of the force 
transmission pathway in talin enabling it to remain folded in the presence of high mechanical 
forces (Yao et al., 2016; Yan et al., 2015). R8 has also been shown to bind to multiple other 
ligands, many of which contain Leucine-Aspartate motifs (LD-motifs) (Alam et al., 2014) 
including (i) Rap1-GTP-interacting adaptor molecule (RIAM), implicated in recruitment of talin 
to the leading edge of cells (Chang et al., 2014; Goult et al., 2013; Lee et al., 2009) and to 
filopodial protrusions (Lagarrigue et al., 2015) (ii) DLC1 (deleted in liver cancer 1), a RhoGAP 
that drives local modulation of actomyosin contractility (Zacharchenko et al., 2016; Li et al., 
2011) and (iii) paxillin a focal adhesion adaptor protein implicated in numerous signalling 
pathways (Zacharchenko et al., 2016). R8 also contains a binding site for vinculin, a protein 
that crosslinks talin to actin and drives focal adhesion maturation (Yogesha et al., 2011; 
Gingras et al., 2010), and the intermediate filament protein α-synemin (Sun et al., 2008). The 
R7 domain also plays a major role in talin function, connecting adhesions to the microtubule 
network. Thus, R7 links to KANK proteins (Bouchet et al., 2016; Sun et al., 2016) which serve 
as platforms for the assembly of large Cortical Microtubule Stabilising Complexes that capture 
microtubules at the periphery of integrin adhesion complexes (Bouchet et al., 2016). This 
complex protein interaction network suggests that R7R8 plays a key role in coordinating 
multiple processes including crosstalk between all three cytoskeletal networks. Mutations in 
talin R7R8, obtained from the Catalogue of Somatic Mutations in Cancer (COSMIC), can 
perturb this coordination and increase invasion and migration in cells (Azizi et al., 2020). 
Previous studies have shown that TLNRD1 is directly targeted by anti-oncogenic miRNAs, 
with an increase in TLNRD1 expression being associated with increased proliferation and 
xenograft growth in hepatocellular carcinoma. In contrast, TLNRD1 depletion reduced bladder 
cancer cell viability, migration and invasion (Tatarano et al., 2012; Wu et al., 2017). Here we 
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show that although TLNRD1 and talin R7R8 both have the same domain structures and 
topology, and both bind actin, TLNRD1 is unique in its ability to bundle F-actin. Our structural 
data show that this is because it dimerizes via its 4-helix module. In U2OS cells, TLNRD1 
localises to thick actin stress fibres and filopodial protrusions, with distinctive localisation to 
the filopodia tips. Overexpression of TLNRD1 also increases filopodia protrusion formation 
and cellular migration in 2D. Finally, we establish biochemically that TLNRD1 can interact with 
known R7R8 LD-motif containing ligands, potentially impacting their ability to interact with talin 
and therefore talin function in cells.  
 
Results 
The structural and sequence similarity of TLNRD1 and talin R7R8 suggest TLNRD1 arose 
through gene duplication. 
Based on sequence homology, TLNRD1 is predicted to have a structure similar to talin R7R8 
with an additional unstructured region at the N-terminus (residues 1-43, Fig. 1B, S1A). The 
structural similarity of TLNRD1 with talin R7R8, plus their 22% amino acid sequence identity 
suggests that TLNRD1 may have originated from a gene duplication event. The TLNRD1 gene 
first appears in choanoflagellates (Monosiga brevicollis and Salpingoeca rosetta) but is absent 
from earlier-diverging Opisthokont protists (e.g. Abeoforma whisleri, Sphaeroforma arctica, 
Capsaspora owczarzaki). This indicates that the gene duplication event that gave rise to 
TLNRD1 occurred around the time of the divergence of choanoflagellates from earlier 
Opisthokonts. A striking feature of the evolutionary history of TLNRD1 is that it is highly 
conserved throughout animal evolution, first appearing in sponges and choanoflagellates but 
absent in Cnidaria, nematodes, and arthropods (Fig. S1B). 
While the R7R8 regions of the two mammalian talin isoforms are each encoded by 11 exons, 
the gene structure of TLNRD1 is markedly different. The entire mammalian TLNRD1 gene 
consists of a single, large exon that encodes the whole protein. One possible explanation for 
the difference in gene structure between talin R7R8 and TLNRD1 is that a section of mature 
spliced talin mRNA encoding R7R8 was reintroduced back into an ancestral animal genome.  
Crystal Structure of TLNRD1 
To determine the extent of the structural similarity of TLNRD1 with talin R7R8, we used X-ray 
crystallography to determine the structures of both the 4-helix domain (143-273, TLNRD1-4H) 
and the full-length protein (1-362, TLNRD1-FL). While the structure of TLNRD1-4H was 
straightforward to determine by molecular replacement with talin R7R8 (PDB: 2X0C (Gingras 
et al., 2010)), the structure of full length TLNRD1 was solved using the BALBES pipeline that 
performs molecular replacement using a repository of diverse structures from the PDB 
database (Long et al., 2008). TLNRD1-FL (PDB: 6XZ4) diffracted to 2.3 Å in P21 space group 
with two TLNRD1 molecules in the asymmetric unit, and TLNRD1-4H (PDB: 6XZ3) to 2.2 Å in 
I4122 space group with one molecule in the asymmetric unit (statistics in Table 1). In the case 
of full-length TLNRD1, electron density could only be traced for residues 40-341, whereas the 
4-helix structure successfully resolved residues 148-270.  
The crystal structures confirmed that TLNRD1 consists of a 9-helix module comprised of a 4-
helix and 5-helix bundle connected via the same unusual domain linkage identified in talin1 
R7R8, where the 4-helix bundle is inserted into a loop between helices α3 and α4 of the 5-
helix bundle (Fig. 1C-F). The first 40 residues of TLNRD1-FL are not visible in the density 
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supporting the secondary structure prediction that this N-terminal region is predominantly 
disordered.  
 
Figure 1. Talin Rod Domain Containing Protein 1 (TLNRD1) is homologous to talin R7R8  
(A) The domain structure of talin. Talin has an N-terminal head domain (residues 1-400) comprising F0-
F3 and a large rod domain comprised of 13 helical bundles, R1-R13 (Goult et al., 2013). The R7 (blue) 
and R8 (orange) domains are highlighted. The 11 vinculin binding sites (VBS) are shown in pink. (B) 
Schematic of the topology of R7R8 (left) and TLNRD1 (right) comprised of a 5-helix bundle (blue) with 
a 4-helix bundle (orange) inserted into the loop between helices α3 and α8. The VBS in R7 and R8 are 
highlighted, but are absent from TLNRD1 due to loss of the VBS consensus sequence (Gingras et al., 
2010). (C) Crystal structure of TLNRD1-FL reveals an antiparallel, symmetric dimer. The domains of 
each monomer are labelled as 4h and 5h, and 4h’ and 5h’. (D) top down view of (C) with the helices 
labelled. The two 4-helix bundles dimerise via an extensive interface comprised of helices α6 and α7. 
(E) Schematic representation of the TLNRD1 dimer. (F) Overlay of the TLNRD1-FL and TLNRD-4H 
structures showing the dimerisation interface is the same in both. (G) Overlay of one monomer of 
TLNRD1 (orange and blue) with R7R8 (grey; PDB ID 2X0C (Gingras et al., 2010)). The individual 
domains are structurally homologous, but the orientation relative to each other is different, with talin 
R7R8 having a more open structure. 
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Table 1. Data collection and refinement statistics for TLNRD1 full-length and 4-helix domain 




Soleil Proxima-1 Soleil Proxima-1 
Space group P21 I4122 
Molecule/a.s.u 
Cell dimensions   
2 1 
    a, b, c (Å) 69.17, 58.04, 84.32 114.59, 114.59, 59.40 
    a, b, g  (°)  90, 106.10, 90 90, 90, 90 
Resolution (Å) 60.22 – 2.30 
(2.38 – 2.30)* 
57.30 – 2.19 
(2.31 – 2.19) 
 Rmerge 0.087 (0.682) 0.130 (1.034) 
I / sI 5.7 (1.3) 12.5 (2.6) 
CC(1/2) 0.994 (0.831) 0.996 (0.938) 
Completeness (%) 98.4 (98.7) 100 (99.9) 
Redundancy 2.8 (2.8) 13.4 (13.6) 
   
Refinement   
Resolution (Å) 2.30 2.19 
No. reflections 27997 (2669) 10464 (2428) 
Rwork / Rfree 0.26/0.31 0.22/0.26 
No. atoms   
    Protein 9047 1903 
    Water 70 38 
B-factors (Å2)   
    Protein 74.25 72.05 
    Water 50.47 56.53 
R.m.s. deviations   
    Bond lengths (Å) 0.004 0.003 
    Bond angles (°) 0.792 0.620 
Ramachandran plot   
    Favoured/allowed/ 
    outlier (%) 
95.20/3.64/1.16 96.69/1.65/1.65 
Rotamer   
    Favoured/poor (%) 88.31/4.18 96.12/0.97 
MolProbity scores    
    Protein geometry 1.75 (97th)^ 1.01 (100th)^ 
    Clash score all atoms 1.88 (100th)^ 1.05 (100th)^ 
PDB accession no. 6XZ4 6XZ3 
 
TLNRD1 is a symmetric antiparallel dimer mediated by the 4-helix bundle. 
Our previous biochemical characterisation using gel filtration suggested that TLNRD1 runs as 
a dimer (Gingras et al., 2010). Here, the two TLNRD1 structures reveal the basis for TLNRD1 
dimerisation which is mediated by a novel interface on the 4-helix bundle. In both the TLNRD1-
FL and TLNRD1-4H structures, the 4-helix bundle forms an extensive interaction with a 4-helix 
bundle of a second TLNRD1 molecule (Fig. 1C). An identical dimer interface was observed in 
both the TLNRD1-FL and the TLNRD1-4H structures (Fig. 1F), which crystallised in different 
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space groups (Table 1). Analysis of the macromolecular interface of the interaction using PISA 
(Krissinel and Henrick, 2007), verified that this was a bona fide dimer.  
Dimerisation of TLNRD1 is mediated via an extensive hydrophobic interface on helices α6 and 
α7 with the two F250 side chains docking into the opposing molecule (Fig. 2A-B). The surface 
of each 4-helix bundle has a pocket created by F270’ and the small side chains of G217’ and 
A260’ that the F250 aromatic rings docks into (Fig. 2B). As it is a symmetric dimer, the F250’ 
docks into the equivalent pocket on the other molecule leading to an antiparallel configuration. 
The interface is capped at either end by electrostatic interactions between the side chains of 
E267 and R246’ and vice versa. Analysis of TLNRD1 over evolution from humans to the 
choanoflagellate, Salpingoeca rosetta, using the program ConSurf (Ashkenazy et al., 2016) 
reveals that these residues which mediate dimerisation are highly conserved (Fig. S2A) 
suggesting that TLNRD1 exists as an obligate dimer. 
 
 
Figure 2. Characterisation of the TLNRD1 dimer. 
(A-B) The symmetrical antiparallel TLNRD1 dimer interface mediated by F250. (B) Zoomed in view. 
One monomer is shown as a surface representation, F250 from the opposing monomer (orange) inserts 
into the pocket on the surface of the other. A salt bridge between R246 and E267’ is shown. (C-D) SEC-
MALS analysis of 106 μM TLNRD1-FL WT (black) and F250D (red). (D) Analysis of the molar mass of 
the major TLNRD1-FL species “a” yields a molecular weight of ~74 kDa. The TLNRD1-F250D yields a 
molecular weight of ~37.8kDa, peak “b”. (E) TLNRD1-FL dimerisation measured using MST at 25°C 
with 40% Red LED laser excitation. Unlabelled TLNRD1-FL was titrated into a fixed concentration (50 
nM) of fluorescently labelled TLNRD1-FL. Data was analysed in MO.Affinity Analysis software (v2.1.3) 
using the law of mass action to generate a dimerisation Kd of 80 ± 0.59 nM. F250D Kd not determined.  
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We used size-exclusion chromatography multi-angle light scattering (SEC-MALS) to explore 
the oligomeric state of the TLNRD1 protein in solution. Both TLNRD1-FL (labelled “a” in Fig 
2C) and TLNRD1-4H were dimeric at 25°C, and no monomer peak was present with either 
construct suggesting a high affinity dimer (Fig. 2C-D). TLNRD1-FL also showed a smaller 
tetramer peak (labelled “b” in Fig 2C), suggesting the presence of a dimer of dimers species. 
To explore the importance of F250 in dimerisation, we generated a point mutant of F250 that 
swapped the aromatic ring for a charged aspartate, F250D (TLNRD1-F250D). The TLNRD1-
F250D mutant was a stable, folded, protein suitable for biochemical analyses (Fig. S2B), 
although the melting temperature, determined using Circular Dichroism, showed a significant 
reduction in thermostability (TLNRD1-FL Tm 69.7°C, TLNRD1-F250D Tm 48°C) (Fig. S2C). 
Analysis of the F250D mutant using SEC-MALS showed a clear transition from a dimeric to 
monomeric state (peak “c”), with only a small proportion remaining as a dimer (peak “d”), 
confirming the importance of this residue in mediating dimerisation (Fig. 2C-D).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
The absence of a monomer peak on SEC-MALS suggests that the dimerisation of TLNRD1 is 
mediated by a high affinity interaction between F250 and the opposing pocket. We therefore 
used Microscale Thermophoresis (MST) to study the monomer-dimer equilibrium. In this 
experiment, unlabelled TLNRD1-FL was titrated against fluorescently-tagged TLNRD1-FL and 
a dimerisation constant (Kd) of 80 nM obtained (Fig. 2E). MST confirmed that the F250D 
mutant prevented TLNRD1 dimerisation, as no Kd was generated. This high affinity suggests 
that TLNRD1 probably exists as an obligate dimer and a F250D mutant renders TLNRD1 
monomeric.  
TLNRD1 has retained the functionality of talin R7R8  
Talin R7R8 has emerged as a multifunctional signalling hub able to bind multiple ligands. Our 
previous studies on DLC1 binding to talin R8 (Zacharchenko et al., 2016; Li et al., 2011) and 
KANK proteins binding to talin R7 (Bouchet et al., 2016) have revealed that both R7 and R8 
talin domains contain binding sites for proteins that contain LD-motifs (Alam et al., 2014). 
Similarly, RIAM and its paralogue lamellipodin have also been shown to interact with talin R8 
via N-terminal LD-motifs (Goult et al., 2013; Chang et al., 2014). Furthermore, talin R7R8 also 
binds to actin filaments (Gingras et al., 2010) as part of actin-binding site 2 (Atherton et al., 
2015; Kumar et al., 2016). 
In light of this diverse R7R8 interactome and structural homology, we wanted to ask whether 
TLNRD1 is also able to bind to talin R7R8 ligands. We first tested RIAM and KANK1 as both 
contain well defined LD-motif talin binding sites, but RIAM binds to the 4-helix domain (R8 in 
talin), whereas KANK binds to the 5-helix domain (R7 in talin). Fluorescence polarisation 
studies showed that purified full-length TLNRD1 protein (residues 1-362, TLNRD1-FL, Fig 3A) 
interacts with RIAM TBS1 (residues 4-30) with a Kd of 0.25 µM (Fig. 3C), an interaction 
mediated by the 4-helix domain. Thus, the purified TLNRD1 4-helix domain alone (residues 
143-273, TLNRD1-4H, Fig 3B) also bound to RIAM TBS1 with high affinity (Kd 0.59 µM) (Fig. 
3D). Lamellipodin, a paralogue of RIAM, also interacts with TLNRD1-4H albeit with a lower Kd 
of 9 µM (Fig. 3D). 
The KANK1 “KN domain” LD-motif peptide (residues 30-60) also bound to TLNRD1-FL (Kd 
11.6 µM) albeit with lower affinity than the 0.8 μM Kd with talin R7 (Fig. 3E). KANK1 binding to 
R7 was previously shown to require the LDLD sequence in the KN domain, with a quadruple 
mutation to alanine (4A mutant) abolishing binding to talin R7. Similarly, this KANK1 4A mutant 
showed a drastic reduction in binding to TLNRD1-FL confirming the interaction was LD-
dependent. Lastly, no interaction was observed with KANK1 KN and TLNRD1-4H (Fig. 3F) 
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confirming that the TLNRD1-KANK1 interaction is mediated via the 5-helix module in TLNRD1. 
Collectively, this biochemical analysis confirms that TLNRD1 has retained the LD-binding sites 
in both the 4-helix, and 5-helix modules after divergence from talin, and by extension that talin 
was able to bind LD-motifs prior to the duplication event.  
 
Figure 3. TLNRD1 has retained the ligand binding sites of talin R7R8 
(A-B) Schematic of the TLNRD1-FL and TLNRD1-4H domain structures (C-F) TLNRD1 binds to LD-
motif containing ligands. (C-D) Binding of fluorescein-labelled RIAM (residues 4-30) peptide with (C) 
TLNRD1-FL and (D) TLNRD1-4H measured using a Fluorescence Polarisation (FP) assay. The binding 
of Lamellipodin (residues 20-46; blue) is also shown. (E-F) Binding of BODIPY-labelled KANK1 
(residues 30-60); wildtype (black) and 4A mutant (blue) peptides (E) binding to TLNRD1-FL and (F) not 
binding to TLNRD-4H, with RIAM (residues 4-30) positive control (black). ND = Not defined, 
experiments performed in triplicate. (G) High-speed actin cosedimentation assay showing that both 
TLNRD1-FL and TLNRD1-4H interact with F-actin. 
 
Another major role of talin R7R8 is to bind actin, and based on this, TLNRD1 was previously 
shown to bind actin (Gingras et al., 2010). Using a high speed cosedimentation assay we 
confirmed that TLNRD1-FL interacts with actin filaments (Fig. 3G). Furthermore, we found that 
TLNRD1-4H alone is capable of interacting tightly with actin (Fig. 3G). This is surprising as, 
by itself, the equivalent 4-helix module in talin, R8, shows little actin binding in cosedimentation 
assays (Gingras et al., 2010), suggesting that TLNRD1 has enhanced actin filament binding. 
Taken together, these data indicate that TLNRD1 is an actin-binding protein that has retained 
functional similarities to talin R7R8. 
TLNRD1 is an Actin-Bundling Protein 
TLNRD1, like talin R7R8, binds to actin in in vitro actin cosedimentation assays (Fig. 3G; 
(Gingras et al., 2010)). In talin, the second actin-binding site (ABS2) maps to domains R4-R8 
in the talin rod, with the two 4-helix bundles, R4 and R8 engaging the actin filament (Fig. 4A) 
(Atherton et al., 2015; Kumar et al., 2016). The actin-binding surface on R8 maps onto one 
face (helices α2 and α3) of the bundle. Our initial hypothesis was that as TLNRD1 was a dimer 
it would also have two 4-helix domains that together might engage a single actin filament in a 
similar fashion to talin ABS2. However, the structure of TLNRD1 dimer shows that the putative 
actin-binding surface on α2 and α3 is positioned facing out from the dimer interface (Fig. 4A). 
This arrangement raised the possibility that TLNRD1 might be able to engage two actin 
filaments simultaneously, and thus crosslink and bundle actin. 
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Figure 4. TLNRD1 is an actin-bundling protein.  
(A) Schematic of the talin actin-binding site 2 (ABS; domains R4-R8) binding a single actin filament 
(left), TLNRD1-FL (middle) and TLNRD1-4H (right) binding to two actin filaments. (B-C) Low-speed actin 
cosedimentation bundling assay with TLNRD1-FL (B) and TLNRD1-4H (C) serial dilution against 25 µM 
F-actin. (D) Transmission electron micrographs of negatively stained F-actin alone (left) and with 
TLNRD1-FL showing bundled actin filaments (right). (E) U2OS cells expressing GFP-TLNRD1 were 
plated on fibronectin, incubated for 2 hr with SiR-actin to label the actin cytoskeleton, and imaged live 
using an Airyscan confocal microscope (1 picture every 16 s; Video S1). Scale bars: (inset) 5 mm. The 
yellow arrows highlight GFP-TLNRD1 localising to actin stress fibres. (F) Random 2D migration assay 
of U2OS cells plated on fibronectin and non-transfected or transiently expressing GFP or GFP-TLNRD1. 
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GFP-TLNRD1 overexpression increases migration velocity in 2D (n = 120 cells from 3 independent 
repeats, ***p value <0.001). Cell trajectories for non-transfected and GFP-TLNRD1 expressing cells are 
shown. (G) High speed actin binding assay of TLNRD1-FL and TLNRD1-F250D showing little impact 
on actin binding with loss of dimerisation. (H) Low speed actin cosedimentation assay showing loss of 
TLNRD1 actin bundling with loss of dimerisation as a result of the F250D mutation.  
 
To establish whether TLNRD1 is also an actin-bundling protein, we used a low speed (10k 
rpm) cosedimentation assay where actin filaments remain in solution and only bundles of actin 
filaments will sediment with bundling proteins. At low speed, actin by itself remained in the 
supernatant, but addition of TLNRD1-FL resulted in a clear increase in the levels of actin in 
the pellet confirming that TLNRD1 is an actin bundler (Fig. 4B). In contrast neither talin R7R8, 
nor ABS2, which are both monomeric are able to bundle actin (Atherton et al., 2015). Following 
on from the discovery that the 4-helix domain of TLNRD1 alone can bind actin filaments (Fig. 
3G), we tested the ability of TLNRD1-4H to bundle actin in the low speed actin 
cosedimentation assay and surprisingly we found that the 4-helix domain by itself, is an 
effective actin bundler (Fig. 4C). To confirm TLNRD1 bundling activity, actin filaments were 
visualised by negative stain electron microscopy both in the absence, or presence, of 
TLNRD1-FL (Fig. 4D). This revealed that TLNRD1-FL can form large bundles of actin 
filaments with tight inter-filament spacing. In addition, TLNRD1 was found to decorate actin 
stress fibres when expressed as N-terminally GFP-tagged (GFP-TLNRD1) in U2OS cells (Fig. 
4E). The effect of TLNRD1 on cell migration was assessed using live-cell imaging of U2OS 
cells plated on fibronectin. Tracking cell migration over time revealed that expression of GFP-
TLNRD1 significantly increased migration velocity compared to non-transfected, or GFP 
expressing, cells (Fig. 4F). 
A key feature which distinguishes TLNRD1 from R7R8 is its dimeric state. To explore the 
importance of TLNRD1 dimerisation in promoting bundling of actin filaments, actin 
cosedimentation assays were performed with the TLNRD1-F250D dimerisation mutant. 
TLNRD1-F250D was still able to bind to actin filaments (Fig. 4G), however, it showed 
significantly reduced actin-bundling activity (Fig. 4H), confirming that dimerisation is required 
for TLNRD1 to bundle actin. As TLNRD1 binds actin considerably more tightly than talin R7R8, 
as well as talin ABS2, and can also drive actin bundling, its interactions with actin are distinct 
from the established talin ABS2 interaction. 
TLNRD1 promotes filopodia formation and co-localises with myosin-X at filopodia tips 
As actin-bundling proteins often contribute to filopodia functions (Gupton and Gertler, 2007; 
Khurana and George, 2011; Jacquemet et al., 2015), we next investigated whether TLNRD1 
might also modulate filopodia formation. U2OS cells were transfected with MYO10-mScarlet 
(to induce and visualize filopodia) together with GFP, GFP-TLNRD1 or GFP-TLNRD1-F250D, 
imaged on a spinning disk confocal microscope, and the number of MYO10-positive filopodia 
was scored (Fig. 5A-B). Over-expression of GFP-TLNRD1 promoted filopodia formation 
whereas the expression of GFP-TLNRD1-F250D did not, indicating that TLNRD1 dimerisation 
is required to promote filopodia formation (Fig. 5A-5B). To further validate a role for TLNRD1 
in modulating filopodia formation, TLNRD1 expression was silenced in U2OS cells using two 
independent small interfering RNAs (siRNAs) (Fig. 5C-D). TLNRD1 gene silencing efficiency 
could be validated using qPCR (Fig. 5C) and western blotting following immuno-precipitation 
(Fig. 5D). Silencing of TLNRD1 led to a decrease in the number of MYO10 filopodia in U2OS 
cells (Fig. 5E). Interestingly, when imaging GFP-TLNRD1 together with MYO10, TLNRD1 
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appeared to localise to filopodia (Fig. 5A). To gain insights into the spatial distribution of 
TLNRD1 in filopodia, U2OS cells transiently expressing mScarlet-MYO10 and GFP-TLNRD1 
or GFP-TLNRD1-F250D were imaged using structured-illumination microscopy (SIM) (Fig. 
5F). The average distribution of these two TLNRD1 constructs in filopodia was then mapped 
as previously described (Fig. 5G) (Jacquemet et al., 2019). Surprisingly, these experiments 
revealed that TLNRD1, unlike other filopodia bundling proteins such as fascin, accumulates 
to filopodia tips. Altogether, our data demonstrates that TLNRD1 is a filopodia tip protein which 
modulates filopodia formation. 
 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted May 19, 2020. . https://doi.org/10.1101/2020.05.19.103606doi: bioRxiv preprint 
12 
 
Figure 5. TLNRD1 localises to, and modulates, filopodia  
(A-B) U2OS cells transiently expressing MYO10-mScarlet and GFP, GFP-TLNRD1 or GFP-TLNRD1-
F250D were plated on fibronectin for 2 hr, fixed, imaged using a spinning disk confocal microscope. 
Representative images are displayed (A). Yellow square highlights region of interest (ROI) which is 
magnified. Scale bar: 25 μm. (B) The number of MYO10-positive filopodia per cell was then quantified 
(n > 125 cells, three biological repeats; *** p value = 0.002). (C-D) Efficiency of siRNA-mediated (oligos 
nos. 6 and 7) silencing of TLNRD1 in U2OS cells as detected using qPCR (C) or western blotting (D). 
To reliably detect TLNRD1 protein levels by western blot, TLNRD1 was first immuno-precipitated from 
cell lysate as indicated. (E) TLNRD1-silenced (oligos nos. 6 and 7) U2OS cells transiently expressing 
MYO10-GFP were plated on fibronectin for 2 hr, fixed, and the number of MYO10-positive filopodia per 
cell was quantified (n >150 cells, three biological repeats; ***p value <0.001). (F-G) U2OS cells 
expressing MYO10-mScarlet and GFP-TLNRD1 or GFP-TLNRD1-F250D were plated on fibronectin for 
2 hr; stained for F-actin and imaged using SIM. (F) Representative maximum intensity projections are 
displayed. The yellow squares highlight ROIs, which are magnified; scale bars: (main) 10 μm; (inset) 5 
μm. (G) Heatmap highlighting the subcellular localization of F-actin, MYO10, TLNRD1 and TLNRD1-
F250D within filopodia based on >360 intensity profiles (see methods for details). P-values were 
determined using a randomization test (see methods for details). 
 
Discussion 
Talin Rod Domain Containing Protein 1 (TLNRD1) shares high sequence and structural 
similarity with the R7R8 region of talin, an important signalling hub which coordinates multiple 
cellular pathways. In this work we have characterised TLNRD1 as a novel actin-bundling 
protein that supports the formation of filopodia.  
Talin R7R8 has been shown to have multifunctional roles; binding to actin and coupling this to 
multiple ligands containing LD-motif sequences. Here we show that TLNRD1 has retained 
R7R8’s diverse interactions through its capacity to bind LD-motifs and actin filaments. With 
the high similarity between talin R7R8 and TLNRD1, it is possible that TLNRD1 might act as 
a dominant negative modulator of talin function, fine-tuning talin signalling responses by 
sequestering R7R8 ligands and thus uncoupling them from their connection to integrin-
mediated adhesion complexes. TLNRD1 binding to LD-motif containing ligands is expected to 
be more diffusive as R7R8 is a part of the talin rod and is more restricted in its mobility as it is 
tethered in adhesive structures. TLNRD1 on the other hand offers the same potential 
functionality but without the key domains of talin which coordinate its adhesion complex 
behaviour. 
Our data also demonstrate that TLNRD1 is an obligate dimer with a mode of actin binding 
distinct from talin ABS2. The orientation of the two TLNRD1 monomers with respect to actin 
allows the dimeric protein to act as an efficient actin bundler. Together, this suggests that 
TLNRD1 can perform similar, as well as distinct, functions to talin R7R8.  
Compact arrangement of the bundles. 
Another notable feature of the TLNRD1 structure is that the 5-helix bundle packs against the 
side of the 4-helix bundle. In contrast, multiple structures of talin1 R7R8 have been solved 
alone (Gingras et al., 2010), and in complex with DLC1 (Zacharchenko et al., 2016) and RIAM 
(Chang et al., 2014), and in all of these structures, there are no interactions between the R7 
and R8 domains, with R8 protruding away from R7.  
In both the TLNRD1 and R7R8 structures, the linker connecting the two domains forms a two-
stranded anti-parallel ß-sheet with complementary backbone hydrogen bonding (Gln-147 
bonds with Ala-282 and Gln-152 with Arg-271 in TLNRD1) holding the two linkers in close 
proximity. This ß-sheet arrangement means there is limited flexibility between the two 
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domains. However, the structures reveal that there is sufficient flexibility to allow both an open 
conformation, as in the talin R7R8 structures, and a more compact arrangement as in the 
TLNRD1 structure. It will be interesting to determine whether opening and closing of the two 
domains relative to each other is of biological relevance; it is tempting to speculate that a 
closed conformation could represent an autoinhibited conformation rendering some binding 
sites cryptic. However, the limited specific inter-domain contacts in the TLNRD1 structure 
suggests that the more compact structure may simply represent tight packing as a result of 
crystal formation, although it is interesting to note that we observe a similar compact 
conformation in solution using Small Angle X-Ray Scattering (SAXS) (Fig. S3). 
The role of TLNRD1 in filopodia functions 
We report here that TLNRD1 localises to and regulates filopodia formation (Figure 5). While 
the precise mechanism by which TLNRD1 induces filopodia remains to be investigated, we 
found that TLNRD1 dimerisation is required. As TLNRD1 dimers can bundle actin and as actin 
bundlers have a well-characterised role in inducing filopodia (Gupton and Gertler, 2007; 
Khurana and George, 2011; Jacquemet et al., 2015) it is tempting to speculate that TLNRD1 
promotes filopodia formation via its actin-bundling property. Interestingly, previously described 
filopodia actin-bundling proteins, such as fascin, typically localise to filopodium shafts 
(Pfisterer et al., 2020) where they tightly pack parallel actin filaments into bundles which allow 
filopodia structures to stabilise (Gupton and Gertler, 2007; Khurana and George, 2011; 
Jacquemet et al., 2015). In particular, the interaction between fascin and actin has been 
recently demonstrated to be the highest at filopodia base (Pfisterer et al., 2020). In contrast, 
TLNRD1 accumulated almost exclusively to filopodium tips and the contributions of an actin 
bundler to filopodia tip functions remains to be studied. 
How TLNRD1 localises to filopodia tips remains unknown, but we speculate that it is via a 
direct interaction with a filopodia tip complex protein. For instance, we demonstrated here that 
TLNRD1 could interact directly in vitro with lamellipodin, which also localises to filopodia tips 
(Krause et al., 2004). Interestingly, TLNRD1 localisation within filopodia is very similar to that 
of talin, which also accumulate at filopodia tips (Jacquemet et al., 2019; Lagarrigue et al., 
2015; Jacquemet et al., 2016). We previously showed that talin regulates filopodia formation 
by tightly coordinating integrin activity within filopodia (Jacquemet et al., 2016; Miihkinen et 
al., 2020). Therefore, future work will aim at investigating the role of TLNRD1 in modulating 
integrin activity in cells and in filopodia.  
Under the radar 
Inspection of the gene expression in the EBI Expression Atlas (Petryszak et al., 2016) shows 
that TLNRD1 is expressed across most tissues throughout embryonic stages and into 
adulthood, suggesting a widespread, cellular function. Yet prior to this work, only a handful of 
papers have looked at this protein. The original name MESDC1 originated from its 
identification as a candidate essential gene for mesoderm development (Wines et al., 2001), 
a role that was later attributed to MESDC2 (Hsieh et al., 2003). Our 2010 study on talin R7R8 
provided the initial characterisation of the MESDC1 protein (Gingras et al., 2010) which 
prompted its renaming to TLNRD1. Since then, TLNRD1 has been implicated as a putative 
oncogene regulated by microRNAs (Wu et al., 2017; Tatarano et al., 2012).  
It is possible to speculate that the lack of focus on TLNRD1 arose due to the confluence of 
several factors. The absence of any reported diseases arising from mutations in TLNRD1 
meant it escaped medical attention, furthermore, TLNRD1 has a unique evolutionary history, 
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showing high conservation throughout vertebrate evolution with early homologs in sponges 
and choanoflagellates but has been lost in some key model organisms including Drosophila, 
yeast and C. elegans. The absence from the model organisms, Drosophila, C.elegans and 
yeast meant it was not picked up in genetic screens. Lastly, until recently the only 
commercially available anti-MESDC1 antibody (Abcam) did not recognise endogenous 
TLNRD1. Unfortunately, we could not study the localisation of endogenous TLNRD1 in cells 
as none of the antibodies we tested worked for immunofluorescence. 
The role of TLNRD1 in cancer 
Two studies on potential oncogenes regulated by anti-oncogenic micro-RNAs; miR-508-5p in 
hepatocellular carcinoma (Wu et al., 2017) and miR-574-3p in bladder cancer (Tatarano et al., 
2012), have both implicated TLNRD1 as a novel oncogene. Interestingly data from  multiple 
databases (Nagy et al., 2018) shows that TLNRD1 mRNA levels often correlate with poor lung 
cancer patients survival.  Our data on over-expression of TLNRD1 in osteosarcoma cells 
indicate that TLNRD1 over-expression drives cell migration. In addition, the number of 
filopodia per cell is significantly increased when TLNRD1 levels are elevated which may drive 
a more invasive morphology (Jacquemet et al., 2017). Future work will aim at elucidating the 
contribution of TLNRD1 to invasive cell migration. 
In summary, we have structurally and biochemically characterised the TLNRD1 protein, as a 
novel actin-bundling protein that can drive filopodia formation and cell migration. In doing so 
we have expanded both the talin family of proteins with the identification of a third talin gene 
and also the growing set of proteins that can polymerise actin filaments into bundles.  
 
Materials and Methods 
Constructs for Biochemical/Structural Assays 
Human TLNRD1 (TLNRD1-FL, residues 1-362) pET151 was purchased as a codon optimised 
synthetic gene from GeneArt (Regensburg, Germany). TLNRD1 4-helix domain (TLNRD1-4H, 
residues 143-273) was sub-cloned into pET151 vector. Single point mutations were introduced 
into TLNRD1 using site directed mutagenesis with Pfu DNA polymerase (Promega, Madison 
US), followed by digestion with DpnI at 37°C for 1 hr and transformation into DH10β E. coli 
cells.  
All expression constructs have been deposited in Addgene www.addgene.org/ben_goult  
Protein Expression and Purification 
TLNRD1 constructs were expressed in BL21(DE3) E. coli cells grown in Lysogeny broth (LB) 
at 37°C with 100 μg/ml ampicillin. Expression was induced with 0.1 mM Isopropyl β-D-1-
thiogalactopyranoside (IPTG) and cells further incubated at 18°C overnight. Following 
centrifugation, pelleted cells were resuspended in nickel affinity buffer (50 mM imidazole, 500 
mM NaCl, 20 mM Tris-HCl, pH 8). Cell lysates were loaded onto a 5 ml HisTrap HP column 
(GE Healthcare) for purification by nickel affinity chromatography, as described previously 
(Khan et al., 2020). Eluted protein was exchanged into MES buffer (20 mM 2-N-
morpholinoethanesulfonic acid, 20 mM NaCl, 2 mM DTT, pH 6.5). His-tags were removed with 
AcTEV protease (Invitrogen) overnight and proteins further purified with a HiTrap SP HP cation 
exchange column (GE Healthcare). 
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Fluorescence Polarisation Assay 
Assays were performed with a serial dilution of protein, with target peptides at a concentration 
of 100 nM. The peptides, synthesised by GLBiochem (China), were coupled with either a 
fluorescein or BODIPY-TMR dye (ThermoFisher). Fluorescence polarisation was measured 
using a CLARIOstar plate reader (BMGLabTech) at 20°C. Data was analysed using GraphPad 
Prism 7 software and Kd values generated with the one-site total binding equation.  
F-actin co-sedimentation Assays 
Actin was isolated from rabbit muscle acetone powder kindly gifted by Professor Mike Geeves 
using a previously described protocol (Spudich and Watt, 1971). Final purified F-actin was 
stored at 4°C in polymerisation buffer (10 mM Tris-HCl pH 7, 50 mM NaCl, 2 mM MgCl2, 1 mM 
NaN3, 1 mM DTT). For cosedimentation assays, F-actin was diluted to 15 µM and incubated 
with a serial dilution of protein starting at a 1:1 ratio for 1 hr at room temperature. To test 
binding, samples were spun at 100,000 x g for 20 min at 4°C. To test bundling activity, samples 
were spun at 10,000 x g for 15 min at 4°C. Equal volumes of pellet and supernatant were 
loaded onto SDS-PAGE gels and densities analysed using ImageJ software (Schneider et al., 
2012). 
Electron Microscopy 
F-actin was diluted to 25 µM in polymerisation buffer. TLNRD1-FL was incubated with the F-
actin at a 1:1 ratio at room temperature for 1 hr. After incubation, samples were diluted down 
to 2 µM with polymerisation buffer. Samples were applied to 300 mesh carbon-coated copper 
grids for 30 seconds, excess solution removed and negatively stained for 1 minute with 2% 
(wt/vol) uranyl acetate. Excess stain was removed and grids washed under a stream of ddH2O. 
Grid samples were dried before imaging. Images were taken on a JEOL-1230 transmission 
electron microscope equipped with a Gatan One View 16 MP camera and an accelerating 
voltage of 80 kV. 
Size Exclusion Chromatography Multi-Angle Light Scattering (SEC-MALS)  
SEC-MALS analysis of TLNRD1-FL and TLNRD1-F250D mutant was performed at room 
temperature with 100 μl of protein at 150 μM. Samples were loaded onto a Superdex 75 size-
exclusion column (GE Healthcare Life Sciences) and eluted proteins measured by Viscotek 
Sec-Mals 9 and Viscotek RI detector VE3580 (Malvern Panalytical). Data was analysed using 
OmniSEC software. 
Crystallisation, X-Ray Data Collection and structure solution 
TLNRD1-FL and TLNRD1-4H crystallisation trials were performed using hanging drop vapour 
diffusion at 21°C with concentrations of 390 µM and 350 µM respectively. Crystals of TLNRD1-
FL were obtained in a condition containing 250 mM NaSCN, 20% PEG3350 and grown to 
optimal size in 7 days. For TLNRD1-4H, crystals were obtained in 300 mM 
HOC(CO2H)(CH2CO2NH4)2, 25% PEG3350 and attained full growth in 4 days. Crystals were 
harvested in their respective growth solutions supplemented with 25% ethylene glycol as 
cryoprotectant, mounted on CryoLoops (Hampton research) or LithoLoops (Molecular 
Dimensions) and vitrified in liquid nitrogen for data collection. X-ray diffraction data sets were 
collected at 100 K at Proxima-1 beamline at Soleil synchrotron (Paris, France) using a Pilatus 
6M detector (Dectris, Baden, Switzerland) and processed by autoPROC pipeline (Vonrhein et 
al., 2011) which incorporates XDS (Kabsch, 2010), AIMLESS (Evans and Murshudov, 2013) 
and TRUNCATE (Evans, 2011) for data integration, scaling and merging respectively. The 
structure of TLNRD1-4H was determined by molecular replacement carried out by PHASER 
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(McCoy et al., 2007) using 2X0C as search model. For the TLNRD1-FL solution BALBES 
molecular replacement pipeline (Long et al., 2008) was employed to generate the initial model 
which was then manually tweaked prior to adjustment and refinement. Manual model 
adjustment was carried out in COOT (Emsley et al., 2010) followed by refinement using 
PHENIX.REFINE (Afonine et al., 2012). Interaction properties of the dimer interface of the 
TLNRD1-FL were assessed by PISA (Krissinel and Henrick, 2007) and figures were prepared 
in PyMOL (Schrödinger LLC, Cambridge MA, USA). Models were validated by MOLPROBITY 
(Chen et al., 2010) prior to deposition.  
Size Exclusion Chromatograph- Small Angle X-ray Scattering (SEC-SAXS) 
SEC-SAXS data was collected at Diamond Light Source beamline B21 (Didcot, UK). TLNRD1-
FL SAXS experiments were performed at 80 µM and 185 µM in 20 mM Tris pH 7, 50 mM 
NaCl, 2 mM DTT. All samples were loaded onto a KW-403-4F 10-600 kDa size-exclusion 
column (Shodex) connected to an Agilent 1200 HPLC system. Data was analysed using 
ScÅtter software available from http://www.bioisis.net/ and ATSAS online services (Franke et 
al., 2017).  
Microscale Thermophoresis 
For investigations into dimerisation, his-tagged TLNRD1 was diluted to 100 nM and coupled 
with His-tag NT-647 dye (RED-tris-NTA NanoTemper, München, Germany) at room 
temperature for 30 min. Unlabelled non-his-tagged TLNRD1 was diluted down to 5 µM. Final 
working concentrations of labelled and unlabelled protein were 50 nM and 2.5 µM respectively 
with the unlabelled protein serially diluted. Samples were loaded into Monolith NT.115 
Capillaries and ran on a Monolith NT.115 (NanoTemper, München, Germany). All experiments 
were run at 25°C with 40% laser excitation. Data was analysed using MO.Affinity Analysis 
v2.3. 
Cell Culture  
For cell culture experiments, N-terminal GFP tagged mouse TLNRD1 was used as previously 
described (Gingras et al., 2010). The mScarlet-MYO10 construct was described previously 
(Jacquemet et al., 2019). Human U2OS osteosarcoma cells (Leibniz Institute DSMZ-German 
Collection of Microorganisms and Cell Cultures, Braunschweig DE) were grown in DMEM 
supplemented with 10% FCS, 2 mM L-glutamine, 1% (vol/vol) penicillin and streptomycin, and 
maintained at 37°C in a humidified 5% CO2 environment. 
Transfection and siRNA knockdown 
Plasmids of interest were transfected using Lipofectamine 3000 and the P3000TM Enhancer 
Reagent (ThermoFisher Scientific) according to the manufacturer’s instructions. The 
expression of proteins of interest was suppressed using 100 nM siRNA and lipofectamine 
3000 (ThermoFisher Scientific) according to manufacturer’s instructions. The siRNA used as 
control (siCTRL) was Allstars negative control siRNA (QIAGEN, Cat. No. 1027281). The 
siRNAs targeting TLNRD1 were purchased from QIAGEN (siTLNRD1#6, Hs_MESDC1_6 
FlexiTube siRNA, Cat. No. SI04217605; siTLNRD1 #7, Hs_MESDC1_7 FlexiTube siRNA, 
Cat. No. SI04314569, siTLNRD1#8, Hs_MESDC1_8 FlexiTube siRNA, Cat. No. SI04362820). 
TLNRD1 Immunoprecipitation 
For immunoprecipitation experiments, U2OS cells were grown to 90% confluency in a 100 mm 
dish and lysed with equal volume of appropriate buffer (40 mM HEPES-NaOH pH 7.4, 75 mM 
NaCl, 2 mM EDTA, 2% NP40). Lysates were cleaned by centrifugation at 10,000 x g for 5 
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minutes at 4°C before 3 hr incubation at 4°C with Dynabeads Protein G superparamagnetic 
beads pre-coated with anti-TLNRD1 antibody or IgG control. Beads were washed three times 
with PBS. Protein extracts were separated under denaturing conditions by SDS–PAGE and 
subjected to western blotting with appropriate primary antibody diluted 1:1000 followed by 
incubation with the appropriate fluorophore-conjugated secondary antibody diluted 1:5000. 
Membranes were scanned using an Odyssey infrared imaging system (LI-COR Biosciences).  
Anti-TLNRD1 antibodies were raised in rabbit against recombinantly expressed human 
TLNRD1 (residues 1-362) by Capra Science (Sweden). The secondary antibody used for 
western blot was an IRDye 800CW conjugated donkey anti-rabbit antibody (Li-Cor, cat 
number 926-32213). 
Sample preparation for light microscopy 
For SIM imaging, U2OS cells transiently expressing GFP-TLNRD1 and Myosin-X-mScarlet 
were plated on high tolerance glass-bottom dishes (MatTek Corporation, coverslip #1.7) pre-
coated first with Poly-L lysine (10 mg/ml, 1 hr at 37°C) and then with bovine plasma fibronectin 
(10 mg/ml, 2 hr at 37°C). After 2 hr, samples were fixed and permeabilised simultaneously 
using a solution of 4% (wt/vol) PFA and 0.25% (vol/vol) Triton X-100 for 10 min. Cells were 
then washed with PBS, quenched using a solution of 1 M glycine for 30 min, and incubated 
with SiR-actin (100 nM in PBS; Cytoskeleton; catalogue number: CY-SC001) at 4°C until 
imaging (minimum length of staining, overnight at 4°C; maximum length, 1 week). Just before 
imaging, samples were washed three times in PBS and mounted in vectashield (Vectorlabs). 
To map the localization of each protein within filopodia, images were first processed in Fiji 
(Schindelin et al., 2012) and data analysed using R as previously described (Jacquemet et al., 
2019). Briefly, in Fiji, the brightness and contrast of each image was automatically adjusted 
using, as an upper maximum, the brightest cellular structure labelled in the field of view. In 
Fiji, line intensity profiles (1 pixel width) were manually drawn from filopodium tip to base 
(defined by the intersection of the filopodium and the lamellipodium). To avoid any bias in the 
analysis, the intensity profile lines were drawn from a merged image. All visible filopodia in 
each image were analysed and exported for further analysis (export was performed using the 
‘‘Multi Plot’’ function). For each staining, line intensity profiles were then compiled and 
analysed in R. To homogenize filopodia length, each line intensity profile was binned into 40 
bins (using the median value of pixels in each bin and the R function ‘‘tapply’’). Using the line 
intensity profiles, the percentage of filopodia positive for each POI was quantified. The map of 
each POI was created by averaging hundreds of binned intensity profiles. 
For the filopodia formation assays, cells were plated on fibronectin-coated glass-bottom 
dishes (MatTek Corporation) for 2 hr. Samples were fixed for 10 min using a solution of 4% 
(wt/vol) PFA, then permeabilised using a solution of 0.25% (vol/vol) Triton X-100 for 3 min. 
Cells were then washed with PBS and quenched using a solution of 1 M glycine for 30 min. 
Samples were then washed three times in PBS and stored in PBS containing SIR-actin (100 
nM; Cytoskeleton; catalogue number: CY-SC001) at 4°C until imaging. Just before imaging, 
samples were washed three times in PBS. Images were acquired using a spinning disk 
confocal microscope (100x objective). The number of filopodia per cell and their length was 
manually scored using Fiji. 
Microscopy setup 
The spinning disk confocal microscope used was a Marianas spinning disk imaging system 
with a Yokogawa CSU-W1 scanning unit on an inverted Zeiss Axio Observer Z1 microscope 
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controlled by SlideBook 6 (Intelligent Imaging Innovations, Inc.). Images were acquired using 
a Photometrics Evolve, back-illuminated EMCCD camera (512 x 512 pixels) and a 100x (NA 
1.4 oil, Plan-Apochromat, M27) objective. 
The confocal microscope used was a laser scanning confocal microscope LSM880 (Zeiss) 
equipped with an Airyscan detector (Carl Zeiss) and a 40x oil (1.4) objective. The microscope 
was controlled using Zen Black (2.3) and the Airyscan was used in standard super-resolution 
mode. 
The structured illumination microscope (SIM) used was DeltaVision OMX v4 (GE Healthcare 
Life Sciences) fitted with a 60x Plan-Apochromat objective lens, 1.42 NA (immersion oil RI of 
1.516) used in SIM illumination mode (five phases x three rotations). Emitted light was 
collected on a front-illuminated pco.edge sCMOS (pixel size 6.5 mm, readout speed 95 MHz; 
PCO AG) controlled by SoftWorx. 
2D Random Migration Assay 
Cells were seeded at a density of 5 x 103 in 1 ml media supplemented with 50 mM HEPES 
on plates coated with 10 μg/ml fibronectin and incubated for 2 hr at 37°C, 5% CO2. Live cell 
imaging was performed on a Nikon Eclipse Ti2-E widefield microscope with a heated CO2 
chamber, Hamamatsu scientific CMOS Orca Flash 4 v4 and 10x Nikon CFI Plan Fluor 
objective. Random migration of cells was measured over 24 hr in a time-lapse movie with 
images taken every 10 min. Manual tracking of cells was performed using Fiji ImageJ 
MTrackJ plugin. The tracked data was analysed using Ibidi chemotaxis and migration tool to 
determine migration speeds, directionality and distance. Graphs of resulting data were 
produced using PlotsOfData (Postma and Goedhart, 2019). Randomization tests were 
performed using the online tool PlotsOfDifferences 
(https://huygens.science.uva.nl/PlotsOfDifferences/) (Postma and Goedhart, 2019).  
Quantitative RT-PCR  
Total RNA extracted using the NucleoSpin RNA Kit (Macherey-Nagel) was reverse transcribed 
into cDNA using the high-capacity cDNA reverse transcription kit (Applied Biosystems) 
according to the manufacturer’s instructions. The RT-PCR reactions were performed using 
predesigned single tube TaqMan gene expression assays and were analysed with the 7900HT 
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Figure S1. (A) Amino acid sequence alignment of human TLNRD1 (UniProt ID: Q9H1K6) and talin1 
residues 1357-1653 encompassing R7R8 (UniProt ID: Q9Y490). Domain boundaries are highlighted 
with orange corresponding to the 4-helix domain and blue corresponding to the 5-helix domain. (B) Tree 
diagram representing TLNRD1 presence and absence over evolution. TLNRD1 first appears in 
choanoflagellates and sponges and is conserved throughout vertebrate evolution. TLNRD1 has been 
lost from Nematodes, Arthropods and Cnidaria. 
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Figure S2. (A) TLNRD1-FL sequence conservation mapped onto the full-length TLNRD1 structure 
using ConSurf (Ashykenazy et al., 2016). Structure coloured according to extent of conservation with 
blue indicating variability and purple indicating highly conserved residues. Residues important for 
dimerisation (Q213, R246, F250, A260, E267) are highlighted. (B) Circular dichroism spectra of 
TLNRD1-FL (black) and TLNRD1-F250D (red) showing no change in overall secondary structure. (C) 
Circular dichroism thermostability analysis of TLNRD1-FL and TLNRD1-F250D showing reduction in 
stability with loss of dimerisation.  
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Figure S3. Small Angle X-Ray Scattering (SAXS) analysis of TLNRD1 shows compact domain 
arrangement in solution. (A-B) SAXS envelope reconstruction with GASBOR, showing (A) the best 
fit with the TLNRD1-FL crystal structure. (B) Top-down view of (A). 
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